Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Rizzuti

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Biological Macromolecules|September 24, 2018
Phosphorylation compromises FAD binding and intracellular stability of wild-type and cancer-associated NQO1: Insights into flavo-proteome stabilityEncarnación Medina-Carmona, Bruno Rizzuti, Rubén Martín-Escolano, et al.
Cells|June 19, 2019
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer CellsRosamaria Lappano, Christophe Mallet, Bruno Rizzuti, et al.
Archives of Biochemistry and Biophysics|January 26, 2022
Biochemical and biophysical characterization of PADI4 supports its involvement in cancerJosé L Neira, Salomé Araujo-Abad, Ana Cámara-Artigas, et al.
Scientific Reports|January 6, 2017
Identification of a Drug Targeting an Intrinsically Disordered Protein Involved in Pancreatic AdenocarcinomaJosé L Neira, Jennifer Bintz, María Arruebo, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative EffectsFedora Grande, Francesca Giordano, Maria Antonietta Occhiuzzi, et al.
Biomolecules|May 24, 2024
Unveiling the Binding between the Armadillo-Repeat Domain of Plakophilin 1 and the Intrinsically Disordered Transcriptional Repressor RYBPSalome Araujo-Abad, Bruno Rizzuti, Miguel Vidal, et al.
Critical Reviews in Oncology/Hematology|August 17, 2025
The mitochondrial catastrophe induced by NUPR1 inhibitors as a novel strategy to fight against cancerJuan Iovanna, Jose Luis Neira, Olga Abian, et al.
Biomolecules|October 23, 2021
Design of Inhibitors of the Intrinsically Disordered Protein NUPR1: Balance between Drug Affinity and Target FunctionBruno Rizzuti, Wenjun Lan, Patricia Santofimia-Castaño, et al.
Biomedicines|April 30, 2021
Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin AnalogsBruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 3, 2019
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs)Francesca Cirillo, Rosamaria Lappano, Leonardo Bruno, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Biological Macromolecules|September 24, 2018
Phosphorylation compromises FAD binding and intracellular stability of wild-type and cancer-associated NQO1: Insights into flavo-proteome stabilityEncarnación Medina-Carmona, Bruno Rizzuti, Rubén Martín-Escolano, et al.
Cells|June 19, 2019
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer CellsRosamaria Lappano, Christophe Mallet, Bruno Rizzuti, et al.
Archives of Biochemistry and Biophysics|January 26, 2022
Biochemical and biophysical characterization of PADI4 supports its involvement in cancerJosé L Neira, Salomé Araujo-Abad, Ana Cámara-Artigas, et al.
Scientific Reports|January 6, 2017
Identification of a Drug Targeting an Intrinsically Disordered Protein Involved in Pancreatic AdenocarcinomaJosé L Neira, Jennifer Bintz, María Arruebo, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative EffectsFedora Grande, Francesca Giordano, Maria Antonietta Occhiuzzi, et al.
Biomolecules|May 24, 2024
Unveiling the Binding between the Armadillo-Repeat Domain of Plakophilin 1 and the Intrinsically Disordered Transcriptional Repressor RYBPSalome Araujo-Abad, Bruno Rizzuti, Miguel Vidal, et al.
Critical Reviews in Oncology/Hematology|August 17, 2025
The mitochondrial catastrophe induced by NUPR1 inhibitors as a novel strategy to fight against cancerJuan Iovanna, Jose Luis Neira, Olga Abian, et al.
Biomolecules|October 23, 2021
Design of Inhibitors of the Intrinsically Disordered Protein NUPR1: Balance between Drug Affinity and Target FunctionBruno Rizzuti, Wenjun Lan, Patricia Santofimia-Castaño, et al.
Biomedicines|April 30, 2021
Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin AnalogsBruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 3, 2019
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs)Francesca Cirillo, Rosamaria Lappano, Leonardo Bruno, et al.
Pageof 10